BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8788039)

  • 1. Distinct patterns of Fas cell surface expression during development of T- or B-lymphocyte lineages in normal, scid, and mutant mice lacking or overexpressing p53, bcl-2, or rag-2 genes.
    Li T; Ramirez K; Palacios R
    Cell Growth Differ; 1996 Jan; 7(1):107-14. PubMed ID: 8788039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
    Van Parijs L; Biuckians A; Abbas AK
    J Immunol; 1998 Mar; 160(5):2065-71. PubMed ID: 9498742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice.
    Strasser A; Harris AW; Corcoran LM; Cory S
    Nature; 1994 Mar; 368(6470):457-60. PubMed ID: 8133891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen.
    Hough MR; Chappel MS; Sauvageau G; Takei F; Kay R; Humphries RK
    J Immunol; 1996 Jan; 156(2):479-88. PubMed ID: 8543797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different developmental arrest points in RAG-2 -/- and SCID thymocytes on two genetic backgrounds: developmental choices and cell death mechanisms before TCR gene rearrangement.
    Diamond RA; Ward SB; Owada-Makabe K; Wang H; Rothenberg EV
    J Immunol; 1997 May; 158(9):4052-64. PubMed ID: 9126963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways.
    Kim K; Lee CK; Sayers TJ; Muegge K; Durum SK
    J Immunol; 1998 Jun; 160(12):5735-41. PubMed ID: 9637482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2.
    Lu L; Chaudhury P; Osmond DG
    J Immunol; 1999 Feb; 162(4):1931-40. PubMed ID: 9973461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
    Aggarwal S; Gupta S
    J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of c-Fos induces apoptosis of CD43+ pro-B cells.
    Hu L; Hatano M; RĂ¼ther U; Tokuhisa T
    J Immunol; 1996 Nov; 157(9):3804-11. PubMed ID: 8892609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas system-mediated apoptosis suppresses lymphopoiesis.
    Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
    J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo.
    O'Reilly LA; Harris AW; Tarlinton DM; Corcoran LM; Strasser A
    J Immunol; 1997 Sep; 159(5):2301-11. PubMed ID: 9278319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
    Nakajima H; Leonard WJ
    J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
    Zhang J; Cado D; Chen A; Kabra NH; Winoto A
    Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of mature B (IgM+, B220+) and T (CD3+) lymphocytes in scid mice.
    Carroll AM; Hardy RR; Bosma MJ
    J Immunol; 1989 Aug; 143(4):1087-93. PubMed ID: 2473116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent reduction of Bcl-2 expression in peripheral T cells of lpr and gld mutant mice.
    Tamura A; Yui K
    J Immunol; 1995 Jul; 155(1):499-507. PubMed ID: 7602121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.
    Grossmann M; O'Reilly LA; Gugasyan R; Strasser A; Adams JM; Gerondakis S
    EMBO J; 2000 Dec; 19(23):6351-60. PubMed ID: 11101508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.
    Jenkins M; Keir M; McCune JM
    J Immunol; 1999 Aug; 163(3):1195-204. PubMed ID: 10415014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells.
    Cory S; Harris AW; Strasser A
    Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):289-95. PubMed ID: 7846127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.